Abstract
An interlaboratory study was conducted to determine whether an enzyme-linked immunosorbent assay (ELISA) with an antigen preparation composed of various-sized fragments of Haemophilus influenzae type b polysaccharide conjugated to human serum albumin could be standardized across laboratories and whether the ELISA-derived results from different laboratories are equivalent to those obtained by the standard radioactive antigen binding assay (RABA) for quantitation of anti-H, influenzae type b polysaccharide antibodies. Twenty coded human serum samples were quantitated by ELISA in 11 laboratories and by RABA in 5 laboratories. The mean RABA-derived values served as the basis for all comparisons. While the overall correspondence of antibody values between the two methods was good, significant differences were found among some of the 11 ELISA data sets and among the mean RABA values. Seven laboratories generated higher ELISA antibody values for low-titered sera. Four laboratories generated antibody concentrations that were not statistically different between the two assay methods. The results therefore indicate that the ELISA can tolerate substantial variations in protocol, such as the use of different plates and different antibody reagents, without affecting the quantitation of serum antibodies. However, attention should be focused on low-titered sera, as some assay conditions may yield spurious results. This ELISA is a serologic assay which can serve as an alternative to the RABA for quantitation of antibodies to H. influenzae type h polysaccharide.
Full Text
The Full Text of this article is available as a PDF (185.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson P. Intrinsic tritium labeling of the capsular polysaccharide antigen of Haemophilus influenzae type B. J Immunol. 1978 Mar;120(3):866–870. [PubMed] [Google Scholar]
- Barra A., Schulz D., Aucouturier P., Preud'homme J. L. Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA. J Immunol Methods. 1988 Nov 25;115(1):111–117. doi: 10.1016/0022-1759(88)90317-1. [DOI] [PubMed] [Google Scholar]
- Edwards K. M., Decker M. D., Palmer P., Porch C. R., Sell S. H., Wright P. F. Lack of comparability between commonly used serological assays of immune response to Haemophilus influenzae vaccine. J Infect Dis. 1987 Feb;155(2):283–291. doi: 10.1093/infdis/155.2.283. [DOI] [PubMed] [Google Scholar]
- FARR R. S. A quantitative immunochemical measure of the primary interaction between I BSA and antibody. J Infect Dis. 1958 Nov-Dec;103(3):239–262. doi: 10.1093/infdis/103.3.239. [DOI] [PubMed] [Google Scholar]
- Johnston R. B., Jr, Anderson P., Rosen F. S., Smith D. H. Characterization of human antibody to polyribophosphate, the capsular antigen of Hemophilus influenzae, type B. Clin Immunol Immunopathol. 1973 Jan;1(2):234–240. doi: 10.1016/0090-1229(73)90024-x. [DOI] [PubMed] [Google Scholar]
- Käyhty H., Mäkelä O., Eskola J., Saarinen L., Seppälä I. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J Infect Dis. 1988 Nov;158(5):973–982. doi: 10.1093/infdis/158.5.973. [DOI] [PubMed] [Google Scholar]
- Käyhty H., Peltola H., Karanko V., Mäkelä P. H. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis. 1983 Jun;147(6):1100–1100. doi: 10.1093/infdis/147.6.1100. [DOI] [PubMed] [Google Scholar]
- O'Reilly R. J., Anderson P., Ingram D. L., Peter G., Smith D. H. Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest. 1975 Oct;56(4):1012–1022. doi: 10.1172/JCI108148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peltola H., Käyhty H., Sivonen A., Mäkelä H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics. 1977 Nov;60(5):730–737. [PubMed] [Google Scholar]
- Phipps D. C., West J., Eby R., Koster M., Madore D. V., Quataert S. A. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods. 1990 Dec 31;135(1-2):121–128. doi: 10.1016/0022-1759(90)90264-v. [DOI] [PubMed] [Google Scholar]
- Plikaytis B. D., Holder P. F., Pais L. B., Maslanka S. E., Gheesling L. L., Carlone G. M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol. 1994 Oct;32(10):2441–2447. doi: 10.1128/jcm.32.10.2441-2447.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pruslin F. H., To S. E., Winston R., Rodman T. C. Caveats and suggestions for the ELISA. J Immunol Methods. 1991 Mar 1;137(1):27–35. doi: 10.1016/0022-1759(91)90390-2. [DOI] [PubMed] [Google Scholar]
- Robbins J. B., Parke J. C., Jr, Schneerson R., Whisnant J. K. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 1973 Mar;7(3):103–110. doi: 10.1203/00006450-197303000-00001. [DOI] [PubMed] [Google Scholar]
- Schlesinger Y., Granoff D. M. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group. JAMA. 1992 Mar 18;267(11):1489–1494. [PubMed] [Google Scholar]
- Smith D. H., Peter G., Ingram D. L., Harding A. L., Anderson P. Responses of children immunized with the capsular polysaccharide of Hemophilus influenzae, type b. Pediatrics. 1973 Nov;52(5):637–644. [PubMed] [Google Scholar]
- Ward J. I., Greenberg D. P., Anderson P. W., Burkart K. S., Christenson P. D., Gordon L. K., Kayhty H., Kuo J. S., Vella P. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol. 1988 Jan;26(1):72–78. doi: 10.1128/jcm.26.1.72-78.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]